Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
Abstract The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a comprehensive comparison of serological COVID-19 assays. We show that the assay detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, had optimal characteristics for antibody detection in different stages of disease..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 23. Apr. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GeurtsvanKessel, Corine H. [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.04.23.20077156 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI017751276 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI017751276 | ||
| 003 | DE-627 | ||
| 005 | 20240425104241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200504s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.04.23.20077156 |2 doi | |
| 035 | |a (DE-627)XBI017751276 | ||
| 035 | |a (biorXiv)10.1101/2020.04.23.20077156 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a GeurtsvanKessel, Corine H. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The world is entering a new era of the COVID-19 pandemic in which there is an increasing call for reliable antibody testing. To support decision making on the deployment of serology for either population screening or diagnostics, we present a comprehensive comparison of serological COVID-19 assays. We show that the assay detecting total immunoglobulins against the receptor binding domain of SARS CoV-2, had optimal characteristics for antibody detection in different stages of disease. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Okba, Nisreen M.A. |e verfasserin |0 (orcid)0000-0002-2394-1079 |4 aut | |
| 700 | 1 | |a Igloi, Zsofia |e verfasserin |4 aut | |
| 700 | 1 | |a Embregts, Carmen W.E. |e verfasserin |4 aut | |
| 700 | 1 | |a Laksono, Brigitta M. |e verfasserin |4 aut | |
| 700 | 1 | |a Leijten, Lonneke |e verfasserin |4 aut | |
| 700 | 1 | |a Rahamat-Langendoen, Janette |e verfasserin |4 aut | |
| 700 | 1 | |a van den Akker, Johannes P.C. |e verfasserin |4 aut | |
| 700 | 1 | |a van Kampen, Jeroen J.A. |e verfasserin |4 aut | |
| 700 | 1 | |a van der Eijk, Annemiek A. |e verfasserin |4 aut | |
| 700 | 1 | |a van Binnendijk, Rob S. |e verfasserin |4 aut | |
| 700 | 1 | |a Haagmans, Bart |e verfasserin |4 aut | |
| 700 | 1 | |a Koopmans, Marion |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 23. Apr. |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:04 |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41467-020-17317-y |x 0 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.04.23.20077156 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 04 | ||